Fundraising FoxMing Med
Guangzhou, CN · 1 known investors
Find your way into Ming Med
Sign up to see every warm intro you have to Ming Med
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ming Med team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Guangzhou Yinming Biomedical Technology is a China-based company developing novel drugs in-house, with a pipeline spanning ophthalmic therapies, recombinant protein botulinum toxin, cancer immunotherapy, and pet immunology drugs. Its research is led by a team of scientists and its main candidates have reached the clinical stage.
Investors · 1
Frequently asked questions
- What does Ming Med do?
- Guangzhou Yinming Biomedical Technology is a China-based company developing novel drugs in-house, with a pipeline spanning ophthalmic therapies, recombinant protein botulinum toxin, cancer immunotherapy, and pet immunology drugs. Its research is led by a team of scientists and its main candidates have reached the clinical stage.
- Who are Ming Med's investors?
- Ming Med's investors include Fuzhou Jiebao Rongan Venture Capital.
- Where is Ming Med headquartered?
- Ming Med is headquartered in Guangzhou, CN.